子宫球囊填塞治疗产后出血的系统综述与荟萃分析
总 pooled 成功率为85.9%(95%CI 83.9-87.9%),子宫收缩乏力(87.1%)和前置胎盘(86.8%)成功率最高,胎盘植入谱系(66.7%)和妊娠物残留(76.8%)最低。随机与非随机研究证据矛盾,实验性研究未显示获益而观察性研究提示有效。
要点
- 子宫球囊填塞治疗严重产后出血总成功率为85.9%(95%CI 83.9-87.9%)。
- 剖宫产分娩成功率(81.7%)低于阴道分娩(87.0%)。
- 随机试验未显示明确获益,观察性研究提示可减少有创操作。
核心结论
- 子宫球囊填塞治疗严重产后出血成功率较高且似乎安全。
- 随机与非随机研究关于疗效和安全性的证据存在矛盾,实验性研究提示无获益而观察性研究相反。
- 需进一步研究确定子宫球囊填塞引入和使用的最有效策略。
研究设计与样本
- 检索电子数据库(建库至2019年8月)及参考文献,纳入随机对照试验、非随机研究和病例系列。
- 主要结局为子宫球囊填塞治疗产后出血的成功率(成功例数/总治疗例数)。
主要发现
- 总 pooled 子宫球囊填塞成功率为85.9%(95%CI 83.9-87.9%)。
- 成功率最高见于子宫收缩乏力(87.1%)和前置胎盘(86.8%),最低见于胎盘植入谱系(66.7%)和妊娠物残留(76.8%)。
- 剖宫产分娩成功率(81.7%)低于阴道分娩(87.0%)。
- 2项随机试验比较子宫球囊填塞与无填塞(阴道分娩后子宫收缩乏力所致产后出血),手术干预或孕产妇死亡风险无显著差异(RR 0.59;95%CI 0.02-16.69)。
- 2项非随机前后对照研究显示,在严重产后出血管理方案中引入子宫球囊填塞显著减少动脉栓塞使用(RR 0.29;95%CI 0.14-0.63)。
关键数值与推荐
- 一项非随机整群研究报告,常规使用子宫球囊填塞的围产网络有创操作显著低于未使用者(3.0/1000 vs 5.1/1000;P<.01)。
- 一项整群随机试验报告,引入子宫球囊填塞后产后出血相关有创操作和/或孕产妇死亡频率显著高于引入前(11.6/10,000 vs 6.7/10,000;P=.04)。
- 归因于子宫球囊填塞使用的并发症频率总体较低(≤6.5%)。
临床怎么用
- 子宫球囊填塞可作为严重产后出血的治疗选择,尤其适用于子宫收缩乏力和前置胎盘。
- 对胎盘植入谱系和妊娠物残留者成功率较低,需警惕失败可能。
- 剖宫产分娩者成功率低于阴道分娩者,临床决策时应考虑分娩方式。
- 现有证据矛盾,引入子宫球囊填塞时应结合机构方案并监测有创操作和母婴结局。
局限性
- 随机和非随机研究证据矛盾,实验性研究提示无获益。
- 纳入研究以病例系列为主(69项),可能存在发表偏倚和异质性。
- 需进一步研究确定最有效的子宫球囊填塞引入和使用策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the efficacy, effectiveness, and safety of uterine balloon tamponade for treating postpartum hemorrhage. STUDY DESIGN: We searched electronic databases (from their inception to August 2019) and bibliographies. We included randomized controlled trials, nonrandomized studies, and case series that reported on the efficacy, effectiveness, and/or safety of uterine balloon tamponade in women with postpartum hemorrhage. The primary outcome was the success rate of uterine balloon tamponade for treating postpartum hemorrhage (number of uterine balloon tamponade success cases/total number of women treated with uterine balloon tamponade). For meta-analyses, we calculated pooled success rate for all studies, and relative risk with 95% confidence intervals for studies that included a comparative arm. RESULTS: Ninety-one studies, including 4729 women, met inclusion criteria (6 randomized trials, 1 cluster randomized trial, 15 nonrandomized studies, and 69 case series). The overall pooled uterine balloon tamponade success rate was 85.9% (95% confidence interval, 83.9-87.9%). The highest success rates corresponded to uterine atony (87.1%) and placenta previa (86.8%), and the lowest to placenta accreta spectrum (66.7%) and retained products of conception (76.8%). The uterine balloon tamponade success rate was lower in cesarean deliveries (81.7%) than in vaginal deliveries (87.0%). A meta-analysis of 2 randomized trials that compared uterine balloon tamponade vs no uterine balloon tamponade in postpartum hemorrhage due to uterine atony after vaginal delivery showed no significant differences between the study groups in the risk of surgical interventions or maternal death (relative risk, 0.59; 95% confidence interval, 0.02-16.69). A meta-analysis of 2 nonrandomized before-and-after studies showed that introduction of uterine balloon tamponade in protocols for managing severe postpartum hemorrhage significantly decreased the use of arterial embolization (relative risk, 0.29; 95% confidence interval, 0.14-0.63). A nonrandomized cluster study reported that use of invasive procedures was significantly lower in the perinatal network that routinely used uterine balloon tamponade than that which did not use uterine balloon tamponade (3.0/1000 vs 5.1/1000; P < .01). A cluster randomized trial reported that the frequency of postpartum hemorrhage-related invasive procedures and/or maternal death was significantly higher after uterine balloon tamponade introduction than before uterine balloon tamponade introduction (11.6/10,000 vs 6.7/10,000; P = .04). Overall, the frequency of complications attributed to uterine balloon tamponade use was low (≤6.5%). CONCLUSION: Uterine balloon tamponade has a high success rate for treating severe postpartum hemorrhage and appears to be safe. The evidence on uterine balloon tamponade efficacy and effectiveness from randomized and nonrandomized studies is conflicting, with experimental studies suggesting no beneficial effect, in contrast with observational studies. Further research is needed to determine the most effective programmatic and healthcare delivery strategies on uterine balloon tamponade introduction and use.
引用
- Suarez S, Conde-Agudelo A, Borovac-Pinheiro A, et al. Uterine balloon tamponade for the treatment of postpartum hemorrhage: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020. PMID: 31917139. doi:10.1016/j.ajog.2019.11.1287
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。